medicalxpress.com
The hidden signals of Crohn's disease: Why remission is not recovery - Medical Xpress
The study suggests that clinical remission on biologics can hide ongoing gut microbiome, metabolite, and epithelial abnormalities that may influence flare risk. This matters because focusing only on immune suppression might miss modifiable factors like diet and epithelial health that could affect long-term outcomes.
Patients with Crohn’s disease (including those in remission and on biologic therapy), gastroenterology clinicians, and researchers studying the microbiome, epithelial biology, or dietary interventions in IBD.
What To Know
What to know This article summarizes findings from the CORE-CD study (published in Gastroenterology) reporting that people with Crohn’s disease who are in clinical remission on biologic therapy still show persistent abnormalities in the gut microbiome, fecal metabolites, diet patterns, and epithelial gene expression (for example, elevated DUOX2 and altered mucin-related activity).
The authors suggest these non-immune signals may help predict flares and could be targets for adjunctive interventions such as dietary change or metabolite supplementation.
Key details The study analyzed multiple omics and clinical groups (active disease, remission, healthy controls) and found that immune markers were suppressed by biologics, but microbial dysbiosis, metabolic differences, and epithelial “high alert” signals persisted in remission.
Higher intake of ultra-processed foods was linked with worse microbial and mucin-related signals; a Mediterranean-style diet correlated with healthier markers. The authors also describe lab-model work prioritizing metabolites that reversed some epithelial dysfunctions in experimental systems.
What this does and does not show This is a research report and interpretation of a published Gastroenterology study; it highlights potential new monitoring targets (epithelial antimicrobial genes) and adjunctive diet/metabolite approaches but does not establish clinical benefit or treatment changes.
Readers should consult their care teams before changing therapies or diets. Summary confidence: medium
Findings come from a multi-omic research study published in Gastroenterology; results are hypothesis-generating and include laboratory model work. The article is a Science X Dialog piece reporting on that research rather than a clinical guideline. Larger clinical trials would be needed before changing standard care.
